What is Insmed's BRINSUPRI — product revenues, net?

Insmed (INSM) reported BRINSUPRI — product revenues, net of $207.85M in Q1 2026.

What does BRINSUPRI — product revenues, net mean?

This metric represents the total net sales generated from the specific product line or business segment after accounting for returns, allowances, and rebates. It serves as a primary indicator of market adoption and commercial success for the company's specialized therapeutic offerings. Tracking this revenue stream is essential for evaluating the segment's contribution to the overall corporate top-line growth and its trajectory toward profitability.

Insmed INSM BRINSUPRI — Product revenues, net

Other product segments

ARIKAYCE external R&D expenses

$98.11M+5.7%

Similar metrics at other companies

BMRNBRINEURA — Total revenues

$47.1M+16.7%

NTICBR — Revenue

$2.06M+35.6%

COLLSegment — Product revenues, net

$193.52M+8.9%

SSTIBR — Revenue

$875K—

XER

XERSProduct revenue, net — Product revenue, net

$82.45M+42.6%

ARDXProduct sales, net — Total revenues

$93.37M+37.7%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total equity$704.9M+611%

Total assets$2.1B+15.2%

Cash flow

See full

Operating cash flow-$222.7M+15.0%

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$25.63B+39.2%

Enterprise value$25.63B+44.8%

P/S31.3×-15.0×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's brinsupri — product revenues, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's BRINSUPRI — product revenues, net?: Insmed (INSM) reported BRINSUPRI — product revenues, net of $207.85M in Q1 2026.
What does BRINSUPRI — product revenues, net mean?: This metric represents the total net sales generated from the specific product line or business segment after accounting for returns, allowances, and rebates. It serves as a primary indicator of market adoption and commercial success for the company's specialized therapeutic offerings. Tracking this revenue stream is essential for evaluating the segment's contribution to the overall corporate top-line growth and its trajectory toward profitability.